New onset diabetes mellitus after solid organ transplantation

Endocrinol Metab Clin North Am. 2007 Dec;36(4):873-90; vii. doi: 10.1016/j.ecl.2007.07.007.


This article presents an overview of the literature on the current diagnostic criteria for new onset diabetes mellitus after transplantation (NODAT) and discusses suggested risk factors for the development of NODAT, its potential pathogenic mechanisms, and its impact on post-transplant outcomes after solid organ transplantation. Suggested guidelines for early identification and management of NODAT are also discussed.

Publication types

  • Review

MeSH terms

  • Adrenal Cortex Hormones / adverse effects
  • Calcineurin Inhibitors
  • Cytomegalovirus Infections / complications
  • Diabetes Mellitus / etiology*
  • Hepatitis C / complications
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Organ Transplantation / adverse effects*
  • Risk Factors
  • Transplantation, Homologous


  • Adrenal Cortex Hormones
  • Calcineurin Inhibitors
  • Immunosuppressive Agents